Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
InChi: InChI=1S/C10H15NO/c1-11(2)8-7-9-3-5-10(12)6-4-9/h3-6
2-dihydroquinoline-3-carboxamido)acetic acid
The comparable efficacy is observed at relatively low doses (10 mg/kg per day)
with no discernible correction in the absence of exogenous zeitgebers in rats
53(3):540-7
ABT-333 Catalog No.:M9232-2 InChi: InChI=1S/C10H15NO/c1-11(2)8-7-9-3-5-10(12)6-4-9/h3-6Dasabuvir, also known as ABT 333, is a non nucleoside polymerase inhibitor currently under clinical trials for the treatment of Hepatitis C. In the United States, it is approved by the Food and Drug Administration for use in combination with ombitasvir, paritaprevir, and ritonavir in the product Viekira Pak. Dasabuvir acts as a NS5B (an RNA directed RNA polymerase) inhibitor. Product information CAS Number: 1132935 63 7 Molecular Weight: 493. 57
US$ 40.00
US$ 109.97
US$ 224.00
US$ 199.90
US$ 374.50
US$ 109.50